NR5A2 and cancer: While some mechanisms, such as Wnt signaling, ALDH1-associated resistance and immune escape ligands, were consistently reported across several cancers, others appeared tumour-specific, such as NR5A2-driven recurrence in PDAC or CD73-associated immune evasion in TNBC.